SIBREAX
LIVE

Serial Number

88219878

Owner

SiBreaX AG

Attorney

Claudia Stangle

Filing Date

Dec 6, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SIBREAX Trademark

Serial Number: 88219878 • Registration: 5953090

SIBREAX is a trademark filed by SiBreaX AG on December 6, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

SiBreaX AG

c/o DMT Treuhand AG
Kilchberg ZH 8802 , CH

Entity Type: 03

Trademark Details

Filing Date

December 6, 2018

Registration Date

January 7, 2020

Published for Opposition

October 22, 2019

Goods & Services

Pharmaceutical preparations for the treatment of cancer, respiratory diseases, liver borne diseases, or for regulation of the immune system; veterinary preparations for the treatment of cancer, for the regulation of the immune system, or for preventing parasites; fungicides, herbicides; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; antibacterial pharmaceuticals; antibiotic preparations; pharmaceutical preparations for the treatment of diseases involving the central nervous system; surgical glues; medical diagnostic reagents; gels for medical or veterinary use, namely, hydrogels for medical or veterinary use, namely for wound healing, wound closure, or surgical applications; galenic formulations for pharmaceutical preparations for the treatment of cancer, respiratory diseases, liver borne diseases, or for regulation of the immune system; insecticides; anti-tumor drugs; pharmaceutical preparations for the treatment of infectious diseases; antiparasitic preparations; pesticides; drug delivery agents in the form of nanoparticles, microparticles, or hydrogels that facilitate the delivery of pharmaceutical preparations; therapeutic medicines and agents for the treatment of cancer, respiratory diseases, liver borne diseases, or for regulation of the immune system

Chemical preparations for use in industry; chemical preparations for scientific purposes; chemical preparations for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; chemical preparations for preventing and treating pathogenic infections in plants; biochemicals for in vitro and in vivo scientific use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; chemical additives for use in the manufacture of cosmetics; diagnostic preparations, other than for medical or veterinary purposes; diagnostic preparations for scientific and research use; catalysts for chemical and biochemical processes; silica gel

Scientific and technological services, namely, research and design in the field of chemistry, biochemistry, biotechnology, pharmaceuticals, cosmetics, or medical technology; testing, analysis and evaluation of goods or services of others in the field of chemistry, biochemistry, biotechnology, pharmaceuticals, cosmetics, or medical technology; agrochemical research services; consultancy in the field of scientific and industrial research; consultancy in the field of pharmaceutical research; product design and development of medical technology; scientific research and new product development services in the field of chemistry; scientific research and new product development services in the field of diagnostic preparations; scientific research and new product development services for the pharmaceutical industry; scientific laboratory research and analysis in the field of chemistry, biochemistry, biotechnology, pharmaceuticals, cosmetics, or medical technology; pharmaceutical research and development; scientific and industrial research in the field of chemistry, biochemistry, biotechnology, pharmaceuticals, cosmetics, or medical technology

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 7, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 3, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 3, 2022 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 3, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 3, 2022 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 2, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 2, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 2, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 2, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2019 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Sep 18, 2019 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 13, 2019 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2019 CRFA
ASSIGNED TO LIE
Sep 9, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 8, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 8, 2019 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 6, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 6, 2019 GNRT
NON-FINAL ACTION WRITTEN
Mar 6, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2018 NWOS
NEW APPLICATION ENTERED
Dec 10, 2018 NWAP